Nuveen’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Sell |
104,991
-87,697
| -46% | -$12.3M | ﹤0.01% | 1429 |
|
|
2025
Q4 | $31.6M | Buy |
192,688
+55,352
| +40% | +$8.67M | 0.01% | 876 |
|
|
2025
Q3 | $18.4M | Buy |
137,336
+3,514
| +3% | +$427K | ﹤0.01% | 1198 |
|
|
2025
Q2 | $16.6M | Sell |
133,822
-145,465
| -52% | -$18.5M | ﹤0.01% | 1217 |
|
|
2025
Q1 | $35.5M | Sell |
279,287
-12,250
| -4% | -$1.89M | 0.01% | 779 |
|
|
2024
Q4 | $42M | Sell |
291,537
-43,567
| -13% | -$6.25M | 0.01% | 737 |
|
|
2024
Q3 | $49.9M | Sell |
335,104
-3,247
| -1% | -$466K | 0.01% | 656 |
|
|
2024
Q2 | $42.7M | Sell |
338,351
-200,079
| -37% | -$31.4M | 0.01% | 697 |
|
|
2024
Q1 | $99M | Sell |
538,430
-2,687
| -0.5% | -$512K | 0.03% | 432 |
|
|
2023
Q4 | $97.3M | Buy |
541,117
+166,998
| +45% | +$26M | 0.03% | 404 |
|
|
2023
Q3 | $59.5M | Buy |
374,119
+159,984
| +75% | +$26.2M | 0.02% | 509 |
|
|
2023
Q2 | $30.3M | Buy |
214,135
+9,825
| +5% | +$1.58M | 0.01% | 821 |
|
|
2023
Q1 | $34.4M | Sell |
204,310
-10,915
| -5% | -$1.95M | 0.01% | 723 |
|
|
2022
Q4 | $36.4M | Sell |
215,225
-49,876
| -19% | -$9.05M | 0.01% | 677 |
|
|
2022
Q3 | $49.6M | Sell |
265,101
-10,061
| -4% | -$2.12M | 0.02% | 532 |
|
|
2022
Q2 | $44.7M | Sell |
275,162
-9,949
| -3% | -$1.57M | 0.02% | 600 |
|
|
2022
Q1 | $53.6M | Buy |
285,111
+62,727
| +28% | +$11.9M | 0.02% | 616 |
|
|
2021
Q4 | $58.9M | Sell |
222,384
-26,444
| -11% | -$7.12M | 0.02% | 602 |
|
|
2021
Q3 | $71.9M | Sell |
248,828
-47,568
| -16% | -$12.2M | 0.02% | 539 |
|
|
2021
Q2 | $59.2M | Sell |
296,396
-1,004
| -0.3% | -$195K | 0.02% | 651 |
|
|
2021
Q1 | $57.8M | Sell |
297,400
-5,069
| -2% | -$1.04M | 0.02% | 656 |
|
|
2020
Q4 | $58M | Buy |
302,469
+70,358
| +30% | +$12.8M | 0.02% | 626 |
|
|
2020
Q3 | $34.2M | Buy |
232,111
+53,947
| +30% | +$7.71M | 0.01% | 739 |
|
|
2020
Q2 | $22M | Sell |
178,164
-236,990
| -57% | -$27.9M | 0.01% | 982 |
|
|
2020
Q1 | $40.1M | Buy |
415,154
+24,310
| +6% | +$2.35M | 0.02% | 573 |
|
|
2019
Q4 | $36.2M | Buy |
390,844
+84,232
| +27% | +$7.08M | 0.01% | 846 |
|
|
2019
Q3 | $23.5M | Sell |
306,612
-55,796
| -15% | -$4.88M | 0.01% | 1040 |
|
|
2019
Q2 | $31.1M | Buy |
362,408
+334,696
| +1,208% | +$22.8M | 0.01% | 918 |
|
|
2019
Q1 | $1.64M | Sell |
27,712
-3,896
| -12% | -$224K | 0.01% | 662 |
|
|
2018
Q4 | $1.67M | Sell |
31,608
-19,681
| -38% | -$1.15M | 0.01% | 640 |
|
|
2018
Q3 | $2.84M | Sell |
51,289
-8,817
| -15% | -$454K | 0.02% | 604 |
|
|
2018
Q2 | $2.83M | Buy |
60,106
+38,860
| +183% | +$1.6M | 0.02% | 569 |
|
|
2018
Q1 | $769K | Hold |
21,246
| – | – | 0.01% | 808 |
|
|
2017
Q4 | $771K | Buy |
21,246
+3,193
| +18% | +$116K | ﹤0.01% | 809 |
|
|
2017
Q3 | $692K | Buy |
+18,053
| New | +$757K | ﹤0.01% | 849 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Nuveen's RGEN Position: Q1 2026 in Review
Nuveen reduced its Repligen (RGEN) stake by 46% in Q1 2026, selling an estimated $12.3M and leaving 104,991 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1429.
Nuveen first reported a position in RGEN in Q3 2017 and has held it in 35 quarters since. The position peaked at $99M in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Nuveen held 104,991 shares of Repligen worth $12.4M as of Q1 2026.
- Nuveen sold 87,697 Repligen shares in Q1 2026, an estimated $12.3M.
- Repligen made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1429 holding.
- Nuveen first reported a position in Repligen in Q3 2017 and has held it in 35 quarters since.
- Nuveen's Repligen position peaked at $99M in Q1 2024.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.